UroToday

AUA 2013 - Session Highlights: Margin rates following minimally invasive surgery may be superior to traditional open radical prostatectomy

Published on Tuesday, 14 May 2013 15:28

SAN DIEGO, CA USA (UroToday.com) - With continued debate regarding the oncologic efficacy of open, laparoscopic, and robotic-assisted radical prostatectomy, a multi-institutional group of authors attempted to compare these modalities using propensity score matching – a statistical approach that attempts to reduce selection bias by controlling for confounding variables.

AUA 2013 - Session Highlights: What is the significance of finding no cancer on repeat biopsy in men on active surveillance?

Published on Tuesday, 14 May 2013 15:14

SAN DIEGO, CA USA (UroToday.com) - Investigators from Canada suggest that no cancer on second biopsy in men on active surveillance portends a good prognosis and may require less intensive follow-up.

AUA 2013 - Session Highlights: Highlights from the Prostate Cancer Screening Session: Impact of the USPSTF recommendations on practice patterns, and new ways to improve detection and reduce complications of prostate needle biopsy

Published on Tuesday, 14 May 2013 15:00

SAN DIEGO, CA USA (UroToday.com) - The prostate cancer screening session at the AUA 2013 in San Diego included several main themes: (1) change in practice patterns following release of the USPSTF’s PSA screening recommendations, (2) improvement of biopsy techniques by integrating MRI technology, and (3) rising rates of complications following repeat prostate biopsy.

AUA 2013 - Session Highlights: Comparison of nomograms vs. multiparametric MRI for prediction of extracapsular extension at time of radical prostatectomy

Published on Tuesday, 14 May 2013 14:00

SAN DIEGO, CA USA (UroToday.com) - Multiple abstracts in the Prostate Cancer Screening I session focus on MRI as a tool to predict extracapsular extension (ECE) and PSA recurrence following prostatectomy.

Leptomeningeal metastasis from prostate cancer - Abstract

Published on Tuesday, 14 May 2013 13:38

Aims and Background: Metastatic prostate carcinoma commonly involves bones and extrapelvic lymph nodes, with occasional visceral deposits.

125I brachytherapy for localized prostate cancer: A single institution experience - Abstract

Published on Tuesday, 14 May 2013 13:32

Aims and Background: To evaluate the clinical outcome of a cohort of localized prostate cancer patients treated with 125I permanent brachytherapy at the University of Turin.

Active surveillance: Patient selection - Abstract

Published on Tuesday, 14 May 2013 13:28

PURPOSE OF REVIEW: This is a summary of the current approach to patient selection for active surveillance, including eligibility criteria, current controversies and the role of imaging.

Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis? - Abstract

Published on Tuesday, 14 May 2013 13:23

Background: Prostate cancer (PCa) is increasingly being diagnosed in China.

AUA 2013 - Session Highlights: Intermittent docetaxel therapy for metastatic prostate cancer. A new paradigm?

Published on Tuesday, 14 May 2013 10:28

SAN DIEGO, CA USA (UroToday.com) - Intermittent androgen deprivation therapy has received significant clinician attention. Now, Japanese researchers have similarly explored intermittent docetaxel dosing for castration resistant prostate cancer (CRPC). Dosing schedules were driven by tracking post-infusion PSA levels. The primary outcomes were differences in adverse effect profiles.

AUA 2013 - Session Highlights: Intermittent androgen ablation for advanced prostate cancer: Pooled analysis from randomized prospective trials

Published on Tuesday, 14 May 2013 10:17

SAN DIEGO, CA USA (UroToday.com) - More data are now available to support intermittent androgen deprivation therapy (ADT) for men with advanced prostate cancer.

Page 7 of 1751